propidium has been researched along with tacrine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Rashid, ZF; Beri, V; Cheung, J; Rosenberry, TL; Shiomi, K; Wildman, SA | 1 |
Dodds, HM; Rivory, LP | 1 |
Aldunate, R; Inestrosa, NC; Muñoz, FJ | 1 |
Cusack, B; Fauq, A; Hughes, TF; Johnson, JL; McCullough, EH; Romanovskis, P; Rosenberry, TL; Spatola, AF | 1 |
Alonso, D; Castro, A; del Monte, M; Dorronsoro, I; García-Palomero, E; Martínez, A | 1 |
de los Ríos, C; García, AG; León, R; López, MG; Marco-Contelles, J; Villarroya, M | 1 |
Bajda, M; Malawska, B; Musiał, A | 1 |
Conde, S; Fernández-Bachiller, MI; García, AG; González-Muñoz, GC; López, MG; Pérez, C; Rodríguez-Franco, MI; Villarroya, M | 1 |
1 review(s) available for propidium and tacrine
Article | Year |
---|---|
Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment.
Topics: Alkaloids; Alzheimer Disease; Binding Sites; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Indole Alkaloids; Isoquinolines; Phenylcarbamates; Physostigmine; Piperidines; Propidium; Rivastigmine; Steroids; Tacrine | 2007 |
7 other study(ies) available for propidium and tacrine
Article | Year |
---|---|
The natural product dihydrotanshinone I provides a prototype for uncharged inhibitors that bind specifically to the acetylcholinesterase peripheral site with nanomolar affinity.
Topics: Acetylcholine; Acetylcholinesterase; Aflatoxin B1; Binding Sites; Binding, Competitive; Catalysis; Catalytic Domain; Cholinesterase Inhibitors; Crystallography, X-Ray; Furans; Humans; Hydrolysis; Kinetics; Models, Chemical; Phenanthrenes; Pyrans; Quinones; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2013 |
The mechanism for the inhibition of acetylcholinesterases by irinotecan (CPT-11).
Topics: Acetylcholinesterase; Acylation; Alzheimer Disease; Binding, Competitive; Butyrylcholinesterase; Camptothecin; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Erythrocytes; Humans; Hydrolysis; Irinotecan; Kinetics; Neostigmine; Propidium; Substrate Specificity; Tacrine | 1999 |
Peripheral binding site is involved in the neurotrophic activity of acetylcholinesterase.
Topics: Acetylcholinesterase; Animals; Binding Sites; Cell Division; Cells, Cultured; Cholinesterase Inhibitors; DNA; Dose-Response Relationship, Drug; Edrophonium; Formazans; Gallamine Triethiodide; Nerve Growth Factors; Neurites; Neurons; PC12 Cells; Propidium; Protein Structure, Tertiary; Rats; Spinal Cord; Tacrine; Tetrazolium Salts | 1999 |
Inhibitors tethered near the acetylcholinesterase active site serve as molecular rulers of the peripheral and acylation sites.
Topics: Acetylcholinesterase; Binding Sites; Cations; Cysteine; Disulfides; Dose-Response Relationship, Drug; Humans; Hydrolysis; Kinetics; Ligands; Models, Chemical; Models, Molecular; Models, Statistical; Mutagenesis, Site-Directed; Mutation; Propidium; Protein Binding; Recombinant Proteins; Tacrine | 2003 |
Synthesis and biological evaluation of tacrine-thiadiazolidinone hybrids as dual acetylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Animals; Binding, Competitive; Cattle; Cell Line, Tumor; Cholinesterase Inhibitors; Erythrocytes; Humans; In Vitro Techniques; Propidium; Structure-Activity Relationship; Tacrine; Thiadiazoles | 2005 |
New multipotent tetracyclic tacrines with neuroprotective activity.
Topics: Acetylcholinesterase; Calcium; Cholinesterase Inhibitors; Cytosol; Humans; L-Lactate Dehydrogenase; Molecular Structure; Neuroblastoma; Neuroprotective Agents; Propidium; Structure-Activity Relationship; Tacrine; Tumor Cells, Cultured | 2006 |
Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Blood-Brain Barrier; Butyrylcholinesterase; Cell Line, Tumor; Cell Survival; Chelating Agents; Cholinesterase Inhibitors; Copper; Humans; Hydroxyquinolines; Magnetic Resonance Spectroscopy; Neuroprotective Agents; Propidium; Spectrometry, Mass, Electrospray Ionization; Tacrine | 2010 |